Hedge Fund Village Capital Partners with Ullink for Post-Trade Support

Implementation extends Village Capital's use of Ullink's XILIX EMS, which now supports a range of post-trade processes.

Singapore
Ullink will now support a range of post-trade processes for Singapore-base hedge fund, Village Capital.

Village Capital, based in Singapore, focuses primarily on Japanese equities across a number of funds with a variety of strategies, including equity long-short and small to mid-cap equities on a long-only basis. The fund, which has been a Ullink client since 2014 when it implemented the vendor’s XILIX EMS, contracted Ullink to help optimize a number of its mainly manual post-trade processes in order to increase efficiencies and reduce the potential for human error and dependency. It is one of Ullink’s first customers to deploy the new XTRAIN post-trade processing component of the vendor’s XILIX suite.

XTRAIN is a cloud-delivered platform designed to support buy-side post-trade processes immediately following trade execution. It comprises three modules focusing on trade matching, portfolio analytics and reporting, and is designed to integrate with XILIX, although it can also be deployed as a standalone platform alongside other EMSs and order management systems.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Waters Wrap: The tough climb for startups

Anthony speaks with two seasoned technologists to better understand why startups have such a tough time getting banks and asset managers to sign on the dotted line.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here